GIROLAMI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.315
EU - Europa 2.696
AS - Asia 1.819
SA - Sud America 226
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 47
OC - Oceania 15
Totale 8.185
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.212
RU - Federazione Russa 713
IT - Italia 678
PL - Polonia 631
SG - Singapore 531
CN - Cina 488
HK - Hong Kong 227
VN - Vietnam 192
BR - Brasile 172
IE - Irlanda 150
KR - Corea 139
SE - Svezia 123
DE - Germania 97
FI - Finlandia 93
CA - Canada 75
FR - Francia 67
BD - Bangladesh 56
IN - India 46
GB - Regno Unito 43
NL - Olanda 38
JO - Giordania 32
JP - Giappone 29
ID - Indonesia 27
AR - Argentina 24
AU - Australia 14
MX - Messico 11
ES - Italia 10
MA - Marocco 10
ZA - Sudafrica 10
BE - Belgio 9
EC - Ecuador 9
TN - Tunisia 9
CO - Colombia 8
IR - Iran 8
CH - Svizzera 7
IQ - Iraq 7
UA - Ucraina 7
AT - Austria 6
RO - Romania 6
TR - Turchia 6
IL - Israele 5
NG - Nigeria 5
PH - Filippine 5
PK - Pakistan 5
CI - Costa d'Avorio 4
JM - Giamaica 4
LT - Lituania 4
CL - Cile 3
CR - Costa Rica 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TC - Turks e Caicos 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 8.119
Salva come PNG Salva come JPEG
Città #
Warsaw 627
Santa Clara 534
Ashburn 436
Singapore 398
Fairfield 206
Hong Kong 201
San Jose 154
Dublin 148
Seoul 138
Hefei 131
Chandler 127
North Bergen 106
Seattle 101
Milan 97
Beijing 94
Houston 91
Dallas 87
Cambridge 81
Wilmington 78
Rome 77
Florence 76
Woodbridge 76
Helsinki 64
Council Bluffs 63
Los Angeles 62
New York 61
Buffalo 54
Munich 52
Hanoi 51
Lawrence 46
Ann Arbor 45
Altamura 41
Ho Chi Minh City 38
Lauterbourg 34
Moscow 32
The Dalles 27
Dong Ket 26
Princeton 26
Jakarta 23
Tokyo 23
Boston 22
Shanghai 20
Turku 19
Kent 18
Toronto 18
Frankfurt am Main 17
Ottawa 16
Bologna 14
Naples 14
São Paulo 14
Turin 14
Paris 13
San Diego 13
Chicago 12
Genoa 12
Melbourne 12
Mumbai 11
Phoenix 11
Medford 10
Chennai 9
Columbus 9
Haiphong 9
Philadelphia 9
Bengaluru 8
Clifton 8
Montreal 8
San Francisco 8
Venice 8
Boardman 7
Brussels 7
Buenos Aires 7
Jacksonville 7
London 7
Norwalk 7
Nuremberg 7
Reading 7
Redondo Beach 7
Stockholm 7
Tehran 7
Brasília 6
Breda 6
Brooklyn 6
Da Nang 6
Denver 6
Johannesburg 6
Lappeenranta 6
Washington 6
Bergamo 5
Bosisio Parini 5
Campinas 5
Figino 5
Lucca 5
Miano 5
Orem 5
Padua 5
Prato 5
Riverside 5
Sousse 5
Sulmona 5
Abidjan 4
Totale 5.377
Salva come PNG Salva come JPEG
Nome #
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. 350
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 317
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations 310
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy 301
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 276
Position paper ANMCO: Cardiomiopatia ipertrofica: dalla diagnosi al trattamento 262
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 255
Clinical Exome Sequencing Revealed a De Novo FLNC Mutation in a Child with Restrictive Cardiomyopathy 244
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 230
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 229
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy insights from the sarcomeric human cardiomyopathy registry (SHaRe) 227
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy 225
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 224
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 222
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 219
Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test Interpretation 215
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 208
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 200
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 195
Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications 194
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 192
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 192
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 189
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 184
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy. 183
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 178
Indicazioni all’esecuzione del test genetico nella diagnosi delle cardiomiopatie ad esordio pediatrico: percorso clinico della Società Italiana di Cardiologia Pediatrica 177
Genetic testing in pediatric cardiomyopathies: Implications for diagnosis and management 171
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome 171
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: Impact of age, atrial remodelling, and disease progression 171
Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy 164
Mitochondrial Energetics and Ca2+-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy 152
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 149
Hidden familial cardiomyopathies in children: Role of genetic testing 145
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy 143
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 142
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 141
Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy 125
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 102
ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment' 38
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 35
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy 31
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 30
Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63 25
MYBPC3 c.2309-2A>G: exploring a founder variant in Italian hypertrophic cardiomyopathy patients 25
Yield of Genetic Testing in Pediatric Cardiomyopathies: Implications for Novel Therapeutic Options 19
Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy 8
Totale 8.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.586
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022217 0 7 16 11 6 20 14 10 20 16 43 54
2022/2023636 46 127 36 28 52 105 90 42 81 5 18 6
2023/2024326 21 28 38 10 18 54 19 77 13 20 16 12
2024/20251.952 68 171 105 308 475 200 31 138 101 64 149 142
2025/20263.201 312 372 369 312 340 102 363 149 227 187 102 366
2026/2027371 244 127 0 0 0 0 0 0 0 0 0 0
Totale 8.185